Picture This — FDA Taking Inspection Photos

Law360, New York (August 22, 2013, 9:25 PM EDT) -- In a draft guidance document issued recently, the U.S. Food and Drug Administration identified four nonexclusive categories of prohibited behavior that the agency considers to constitute “delaying, denying, limiting or refusing a drug inspection.” In particular, the new guidance expands the FDA’s power to photograph during inspections and characterizes attempts to limit photography as a prohibited behavior.

Section 707 of the Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. 112-144, provides the FDA discretion to deem any drug adulterated that was “manufactured, processed,...
To view the full article, register now.